
Meneldor
Europe, Gelderland, The Netherlands, Druten
Description
Meneldor is a biopharmaceutical investment company .
Investor Profile
Meneldor has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 83% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Debt Financing, Seed rounds (top funding stages).
- Majority of deals are located in Germany, Norway, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.
Stage Focus
- Series A (67%)
- Debt Financing (17%)
- Seed (17%)
Country Focus
- Germany (33%)
- Norway (33%)
- United Kingdom (17%)
- The Netherlands (17%)
Industry Focus
- Biotechnology
- Health Care
- Health Diagnostics
- Pharmaceutical
- Biopharma
- Therapeutics
- Consulting
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.